TGFB1 and hepatocellular carcinoma: Future studies in longitudinal and advanced-stage HCC cohorts will be essential to define the optimal therapeutic window and to disentangle the dualistic role of TGF-β in maintaining tissue homeostasis versus mediating immune suppression.